Clinical trial

CK-0045 Proof-of-concept Study in Participants With Overweight / Obesity and Type 2 Diabetes

NCT06611930

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2024-09-06

PhasePHASE2

Study timeline

Study start (actual)2024-09-06Date precision: day

Registry last updated2026-02-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitus (T2DM)unresolved

Obesity and Overweightunresolved

Interventions

CK-0045DRUG

PlaceboDRUG

Sponsors & collaborators

Cytoki Pharmalead sponsor

Profil Institut für Stoffwechselforschung GmbHcollaborator

CRS Clinical Research Services Mannheim GmbHcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06611930 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.